Cargando…
Adjuvant Chemotherapy of Non-Small Cell Lung Cancer
Approximately 25-30% of patients with non-small cell lung cancer (NSCLC) present with early stage disease and undergo surgery with curative intent. Despite complete tumor resection, many of these patients will develop systemic relapses with or without local relapses and will eventually die from the...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
National Research Institute of Tuberculosis and Lung Disease
2012
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4153177/ https://www.ncbi.nlm.nih.gov/pubmed/25191395 |